HighLight Capital (HLC) is a private investment firm dedicated to creating long-term values through promoting technology innovations. Empowered by our deep knowledge in chemical, biological and material sciences, and leveraging our proprietary industry research and comprehensive enablement services, we strive to invest in companies that boost manufacturing efficiency and improve human wellness. HLC currently manages over US$3.8 billion, with operations across in key financial hubs, such as Tokyo, Shanghai, Hong Kong and Boston.

Biotechnology

Chemicals

Investment Management

Life Sciences

Manufacturing

HighLight Capital

The Shanghai office focuses on strategic partnerships and AI innovation, supporting investment analysis and research initiatives.

Shanghai

The Beijing office focuses on healthcare investment and strategic leadership in the Chinese market.

Beijing

The Hong Kong office serves as a strategic hub for executive leadership and educational initiatives in the Asia-Pacific region.

People (3)

Jobs (0)

Other offices